About this trial
The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:
-To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support.
Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.
Eligibility criteria
Qualifiers
12-17 years old
Identify as Black or African American or being of African descent
Have current suicidal ideation or suicidal ideation within the last 30 days
Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.
Disqualifiers
An active psychotic disorder or current psychosis symptoms
No history of suicide attempt(s) or suicide ideation in the past 30 days
Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF & SSP
Caregivers, guardians, and/or the patient refuse to participate.
Trial design
Treatments tested in this trial
- Bridge the Gap (BTG) - Black Youth Group
Treatment groups
Sponsors and collaborators
Children's Hospital Los Angeles
Lead sponsor
American Psychological Foundation
Collaborator